Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
ClinicalTrials.gov study NCT01177540. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
ClinicalTrials.gov study NCT02196857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)
ClinicalTrials.gov study NCT02773732. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT03941964. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients with Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03150004. IPD Sharing: NO. Countries: 1. Publications: 2.
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
ClinicalTrials.gov study NCT02719574. IPD Sharing: Not stated. Countries: 9. Publications: 5.
A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
ClinicalTrials.gov study NCT02488408. IPD Sharing: YES. Countries: 4. Publications: 16.
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02464657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00691938. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
ClinicalTrials.gov study NCT02771197. IPD Sharing: NO. Countries: 1. Publications: 24.
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
ClinicalTrials.gov study NCT00373529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01106950. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients
ClinicalTrials.gov study NCT02109744. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients
ClinicalTrials.gov study NCT02845297. IPD Sharing: NO. Countries: 1. Publications: 1.
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
ClinicalTrials.gov study NCT00789256. IPD Sharing: Not stated. Countries: 1. Publications: 20.
APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03931291. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
ClinicalTrials.gov study NCT06578247. IPD Sharing: YES. Countries: 28. Publications: 0.
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03303339. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
ClinicalTrials.gov study NCT01757535. IPD Sharing: Not stated. Countries: 23. Publications: 8.
MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
ClinicalTrials.gov study NCT02395822. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.